Kolexia
Gandemer-Delignieres Virginie
Pédiatrie
Hôpital Sud Rennes
Rennes, France
292 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémies Leucémie-lymphome lymphoblastique à précurseurs B et T Leucémie aigüe myéloïde Maladie du greffon contre l'hôte Leucémie myéloïde Maladie aigüe Maladie veno-occlusive hépatique Maladie résiduelle Tumeurs hématologiques

Industries

Servier
7 collaboration(s)
Dernière en 2023
Novartis
6 collaboration(s)
Dernière en 2023
Jazz Pharmaceuticals
2 collaboration(s)
Dernière en 2021
Sanofi
1 collaboration(s)
Dernière en 2020

Dernières activités

A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia: ALLTogether1 - A Treatment Study Protocol of the ALLTogether Consortium for Children and Young Adults (0-45 Years of Age) With Newly Diagnosed Acute Lymphoblastic Leukaemia (ALL)
Essai Clinique (Mats Heyman)   18 mars 2024
A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Children and Teenage Transplant Recipients With CMV Infection: A Phase 3, Open-label, Single-arm, Repeated-dose Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic Stem Cell Transplant (HSCT) or a Solid Organ Transplant (SOT)
Essai Clinique (Takeda Pharmaceutical)   08 mars 2024
A predictive classifier of poor prognosis in transplanted patients with juvenile myelomonocytic leukemia: a study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire.
Haematologica   22 février 2024
X-MAIDReg: Etude Multicentrique Internationale rétrospective Des Patients Atteints de déficit Immunitaire associé à la moésine lié au Chromosome X (X Maid Pour X-linked Moesin Associated Immunodeficiency)
Essai Clinique (Institut National de la Santé Et de la Recherche Médicale, France)   19 février 2024
Therapeutic drug monitoring of imatinib - how far are we in the leukemia setting?
Expert review of clinical pharmacology   12 février 2024
Treatment Duration and Complete Response (CR) in Adult and Pediatric Patients (Pts) Treated with Defibrotide (DF) for Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) after Hematopoietic Cell Transplantation (HCT) in the Defifrance and EBMT PASS Registries
Abstracts from the 2024 Tandem Meetings of ASTCT and CIBMTR, February 21-24, 2024, San Antonio, Texas, USA   01 février 2024
A software tool to support follow-up care in a French childhood cancer cohort: construction and feasibility.
BMC cancer   25 janvier 2024
Educational outcomes in siblings of childhood leukemia survivors: Factors associated with school difficulties and comparison with general population.
Cancer medicine   10 janvier 2024
A 2023 inventory in oncology news.
Bulletin du cancer   05 janvier 2024
GATA-2 Project: Retrospective and Prospective Exploratory Study for Characterisation of Predictive Parameters of Clonal Evolution in Subjects With GATA2 Germline Mutation
Essai Clinique (Institut Universitaire du Cancer Toulouse Oncopole)   11 décembre 2023